Logo Image
|Videos|January 12, 2022

Mirvie RNA test aims to predict pregnancy complications

Author(s)Morgan Ebert

Maneesh Jain, CEO and co-founder of Mirvie, a proprietary RNA platform that uses blood samples to predict pregnancy complications such as preeclampsia, sits down with Contemporary OB/GYN to discuss the potential of the test.

Related Content

Latest CME

Join Us at The Pathology Meeting in Las Vegas
In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

View more
Join Us at The Pathology Meeting in Las Vegas
In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

View more
SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer
Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

View more